Mississippi House Bill HB662

Mississippi 2022 Regular Session

• Introduced: 1/17/22
• Refer: 1/17/22
• Failed: 2/1/22

Caption

Tianeptine; add to Schedule II list of controlled substances.

Impact

By elevating Tianeptine to Schedule II status, the bill introduces stricter controls regarding its prescription and dispensing. This classification means that healthcare providers will need to exercise greater caution when prescribing Tianeptine and that pharmacies will have to adhere to more stringent guidelines around its procurement and distribution. The intent behind this measure is to mitigate the risks of abuse and dependency on substances that are treated similarly to classical opioids.

Summary

House Bill 662 aims to amend Section 41-29-115 of the Mississippi Code of 1972 by adding Tianeptine to the list of Schedule II controlled substances. This amendment signifies a considerable regulatory change concerning the classification of Tianeptine, which is often used as an antidepressant but has been associated with misuse and addiction in some contexts. The bill seeks to regulate this substance more stringently to curb potential abuse and protect public health.

Contention

While some support the bill for its potential to curb substance abuse, there may be concerns over access for patients who legitimately need Tianeptine for mental health treatment. Critics of stricter drug scheduling often argue that it can hinder patients' access to necessary medications. Therefore, the debate may revolve around balancing the needs of patients with the imperative of public health and safety. As Tianeptine is not as widely known as other opioids, discussions in legislative circles may reflect a lack of awareness of its clinical uses and the extent of its abuse potential.